Medtronic plc
Company Stats
- Market Cap
- $110.4B
- as of Sep 30, 2026
- Enterprise Value
- $136.6B
- Shares Outstanding
- 1.3B
- Free Float
- 99.7%
Income Statement
- Revenue
- $36.4B
- Operating Income
- $6.5B
- Net Income
- $4.8B
- EBITDA
- $9.4B
- Revenue Growth, 3Y
- 5.2%
- FCF Margin, 3Y Avg
- 15.5%
- FCF Margin, Worst Year
- 14.9%
Cash Flow
- Free Cash Flow
- $5.4B
- FCF Yield
- 4.9%
- Owner FCF Yield
- 4.5%
Balance Sheet
- Cash & Equivalents
- $1.9B
- Total Debt
- $28.1B
- Net Debt
- $26.2B
- Net Debt / EBITDA
- 2.78x
- EV / EBITDA
- 14.49x
- Net Debt / EBIT
- 4.05x
Returns & Capital
- Dividends Paid
- $3.6B
- Dividend Yield
- 3.3%
- Dividend Payout, 3Y Avg
- 84.2%
- Share Repurchases
- $1.0B
- Buyback Yield, 3Y Avg
- 1.9%
- SBC, 3Y Avg
- $426.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2026 | $36.4B | $5.4B | 14.9% |
| FY2025 | $33.5B | $5.2B | 15.5% |
| FY2024 | $32.4B | $5.2B | 16.1% |
| FY2023 | $31.2B | $4.6B | 14.7% |
| FY2022 | $31.7B | $6.0B | 18.9% |
Annual filing data through FY ended April 24, 2026; shares and float as of October 13, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Input Costs Squeeze Margins Even as Demand Holds Firm
Five Below, Medtronic Lead June 3 Earnings Wave